Liraglutide Cost Breakdown: Brand, Compounded, Insurance & Savings Options

Introduction

Liraglutide is the original daily GLP-1 receptor agonist. Novo Nordisk sells it under two brand names. Saxenda® is approved for chronic weight management. Victoza® is approved for type 2 diabetes. Both cost about the same out of pocket, around 1,300 to 1,500 dollars a month at list price.

The interesting wrinkle: liraglutide lost its primary patent in 2024. Generic and authorized-generic versions started landing in 2024 and 2025 at roughly 60 to 70 percent below brand pricing. Hikma Pharmaceuticals launched the first generic liraglutide for diabetes in late 2024. That changed the pricing math fast.

Here’s what you’ll actually pay in 2026, sorted by route to the medication.

At TrimRx, we believe that understanding your options is the first step toward a more manageable health journey. You can take the free assessment quiz if you’re ready to see whether a personalized program is a fit for you.

What Is the List Price of Brand Liraglutide?

Saxenda’s wholesale acquisition cost was 1,349.02 dollars per month as of early 2026, per Novo Nordisk’s published pricing data. That covers one carton, which is five 3-mL pens delivering up to 3 mg daily for 30 days at the maintenance dose.

Quick Answer: Saxenda list price is roughly 1,349 dollars per month (5 pens, 18 mg total)

Victoza’s WAC was 1,055 dollars per month for the same five-pen carton, dosed up to 1.8 mg daily. The price gap reflects the dose, not the molecule. You’re paying for milligrams of liraglutide. Saxenda’s max dose is 3.0 mg, Victoza tops out at 1.8 mg.

These are list prices, not what most patients pay. Pharmacy benefit managers negotiate rebates, and cash-pay programs cut a different deal. The 1,349 number rarely shows up on an actual receipt.

How Much Does Generic Liraglutide Cost?

Hikma’s authorized generic injection (the same molecule, same delivery device, made by Novo Nordisk under contract) priced at roughly 469 dollars per month at launch, a 65 percent discount to Saxenda. That’s the WAC. Cash-pay coupons at GoodRx have shown the generic as low as 385 dollars for a 30-day supply at some chains.

Teva and Sandoz both filed ANDA applications and Sandoz received approval in late 2024. Pricing competition among three generic makers has pushed retail closer to 320 to 400 dollars cash. That’s still expensive compared with metformin, but it’s a real shift from brand pricing.

The generic is identical to Saxenda in active ingredient and pharmacokinetics. The 2010 STEP-equivalent data on weight loss outcomes (8 percent average loss at 56 weeks per the SCALE trial, Pi-Sunyer et al. 2015 NEJM) applies to generic and brand alike.

Is Compounded Liraglutide Still Available?

Mostly no. The FDA removed liraglutide from its drug shortage list in 2024 after Novo Nordisk restored full supply. Section 503A and 503B pharmacies can compound a drug only when it appears on the shortage list or when the prescription is for an individualized medical need.

A handful of compounding pharmacies still produce liraglutide for specific patient cases, like documented allergic reactions to brand inactives, but routine bulk compounding ended in 2024. The compounded prices people remember (200 to 350 dollars a month) are no longer the typical out-of-pocket cost.

If you see a telehealth site advertising compounded liraglutide for under 300 dollars a month in 2026, ask for the legal basis. The honest answer is usually that they’re offering compounded semaglutide instead, since semaglutide remained on the shortage list longer.

Will Insurance Cover Liraglutide for Weight Loss?

Saxenda is covered for chronic weight management by some commercial plans, almost no Medicare plans (until the 2026 expansion below), and a patchwork of state Medicaid programs. The standard prior authorization requires a BMI of 30 or higher, or 27 or higher with a weight-related comorbidity like type 2 diabetes, hypertension, or dyslipidemia.

In 2026, CMS expanded Medicare Part D coverage of GLP-1s with cardiovascular indications, following the SELECT trial precedent. Saxenda is not yet on that list because it lacks a dedicated CVD trial. Patients with type 2 diabetes can usually get Victoza covered under Part D since it carries a diabetes indication.

A 2024 KFF analysis found that 43 percent of large employer-sponsored plans covered GLP-1s for obesity, up from 26 percent in 2022. Coverage often requires prior auth and step therapy through phentermine or orlistat first.

What Is the Novo Nordisk Savings Card for Saxenda?

Novo Nordisk’s Saxenda Savings Card brings the monthly copay to as low as 25 dollars for commercially insured patients, capped at 200 dollars off per month, with a maximum benefit of 1,800 dollars per year. The card is not valid for federal or state-funded plans like Medicare, Medicaid, TRICARE, or VA.

The card has been available since Saxenda launched in 2014 and Novo updates the terms periodically. As of 2026, the maximum benefit and 200 dollar monthly cap have stayed constant for three years even as list prices climbed. Effective discount is shrinking.

For Victoza, Novo’s savings card brings copay to as low as 25 dollars per month with a 150 dollar monthly cap. The card was extended through 2026 despite the generic launch.

How Does Liraglutide Cost Compare with Semaglutide and Tirzepatide?

At brand list price in 2026:

• Wegovy® (semaglutide for obesity): about 1,349 dollars per month
• Zepbound® (tirzepatide for obesity): about 1,086 dollars per month
• Saxenda (liraglutide for obesity): about 1,349 dollars per month

So Saxenda matches Wegovy at list. The catch is that Saxenda needs daily injections versus weekly for the others, and produces less weight loss on average (about 8 percent at one year for liraglutide vs. 15 percent for semaglutide in STEP 1 Wilding et al. 2021 NEJM, and 21 percent for tirzepatide in SURMOUNT-1 Jastreboff et al. 2022 NEJM).

Cost per pound of weight loss favors the newer molecules even before discounts. That math is why most new patients in 2026 start on semaglutide or tirzepatide, not liraglutide, unless cost or supply pushes them toward generics.

What Does Liraglutide Cost Without Insurance?

Without coverage, in 2026 you’re looking at three realistic options:

1. Brand Saxenda with the savings card, around 200 to 300 dollars per month for the first 6 months, then the cap resets per calendar year
2. Generic liraglutide at retail pharmacies, 320 to 400 dollars cash per month
3. Brand Victoza with savings card for diabetes patients, 25 dollars per month if eligible

Pharmacy comparison tools like GoodRx and Cost Plus Drugs (Mark Cuban’s outfit) sometimes list generic liraglutide under 300 dollars. Cost Plus listed it at 287 dollars in March 2026 for the 18 mg/3 mL pen pack. Stock varies by week.

For a TrimRx personalized treatment plan, our medical team evaluates semaglutide and tirzepatide based on clinical fit, not liraglutide, since the newer GLP-1s show better tolerability and weight outcomes. Cost discussions happen during the free assessment quiz.

Key Takeaway: Authorized generic liraglutide injection launched 2024, priced 60 to 70 percent below brand

Does Medicare Cover Liraglutide in 2026?

Partially. The Inflation Reduction Act allowed CMS to negotiate Medicare Part D drug prices, and the second wave of negotiations announced in 2025 included Victoza. Negotiated Maximum Fair Prices take effect January 2027, with Victoza’s MFP set at 419 dollars per month, a 60 percent cut from current Part D plan costs.

For 2026, Victoza is covered under most Part D plans for type 2 diabetes with typical copay tiers of 47 to 95 dollars depending on plan formulary. Saxenda remains uncovered by traditional Medicare for weight loss, but the 2026 cardiovascular outcomes expansion covers Wegovy for patients with established CVD. Liraglutide doesn’t have an equivalent CVD label.

Medicare Advantage plans vary. Some include weight loss benefits with prior auth.

What About Cardiovascular Benefit and Cost-effectiveness?

The LEADER trial (Marso et al. 2016 NEJM) showed liraglutide reduced major adverse cardiovascular events by 13 percent in patients with type 2 diabetes and high CVD risk. That data drove FDA approval of an expanded indication.

ICER published a cost-effectiveness analysis in 2022 that pegged liraglutide for obesity at roughly 237,000 dollars per quality-adjusted life year at then-current pricing, well above the 100,000 to 150,000 threshold ICER uses as “fair value.” Generic liraglutide at 400 dollars per month brings the QALY into a more reasonable range, around 95,000 to 110,000 dollars depending on assumptions.

That cost-effectiveness logic explains why payers are now more willing to cover generic liraglutide than brand Saxenda for obesity. The pharmacoeconomics finally pencil.

How Do I Appeal a Liraglutide Insurance Denial?

If your plan denies Saxenda coverage, you have three escalation routes:

1. Standard appeal with letter of medical necessity from your prescriber, citing BMI, comorbidities, prior weight loss attempts, and clinical guidelines (Obesity Society 2022 and Endocrine Society 2023)
2. Peer-to-peer review where your doctor speaks directly with the plan’s medical director
3. External review through your state insurance commissioner if the internal appeal fails

A 2024 study in Health Affairs (Madden et al.) reviewed 14,000 GLP-1 prior auth requests and found that 31 percent of initial denials were overturned on appeal. The strongest cases included documented BMI 30+, two or more comorbidities, and failed prior pharmacotherapy.

For the diabetes indication of Victoza, denials are rare. For Saxenda, expect to fight.

How Much Does Liraglutide Cost Over a Year of Treatment?

The annualized math matters more than monthly snapshots for patients planning long-term therapy. Several scenarios:

Brand Saxenda with the Novo savings card, commercially insured: roughly 25 dollars per month for the first 6 months (until the 1,800 dollar annual cap is exhausted), then either full copay or list price for the remaining 6 months. Total annual cost approximately 6,000 to 9,000 dollars depending on plan.

Generic liraglutide at Cost Plus Drugs or with GoodRx coupons, uninsured: 287 to 400 dollars per month, total annual cost approximately 3,500 to 4,800 dollars.

Medicare Part D, diabetes indication, Victoza covered: typical annual out-of-pocket approximately 600 to 1,200 dollars after the 2,000 dollar annual cap took effect in 2025.

LillyCares free medication program for uninsured patients below 400 percent FPL: zero dollars after application approval, ongoing for as long as eligibility is maintained.

For TrimRx personalized treatment plans, our medical team typically recommends semaglutide or tirzepatide based on better weight loss outcomes, and discusses pricing options during the assessment process.

What Questions Should I Ask About Liraglutide Cost?

When discussing liraglutide options with a prescriber or pharmacy, useful questions include:

1. Is brand Saxenda or generic liraglutide on my plan’s formulary?
2. What’s the prior authorization process for the obesity indication?
3. Does the manufacturer savings card apply to my insurance plan?
4. Can my prescriber send the prescription to a pharmacy that offers cash-pay discounts?
5. Are there ongoing assistance programs I might qualify for based on income?

The answers vary by plan, region, and pharmacy. A 15-minute phone call with the pharmacy team can save hundreds of dollars per month in some cases.

Bottom line: Medicare Part D added Saxenda coverage in 2026 for select beneficiaries with cardiovascular indications

FAQ

Is Generic Liraglutide as Effective as Saxenda?

Yes. The FDA requires generic injectables to demonstrate the same active ingredient at the same concentration with comparable pharmacokinetics. Generic liraglutide from Hikma is manufactured by Novo Nordisk under contract using the same facility and process, so it’s bioidentical.

Why Is Saxenda Still on the Market If Generics Exist?

Patent litigation and exclusivity periods extend Novo’s right to keep selling under the Saxenda brand. Generics compete on price but Saxenda holds about 78 percent of the obesity prescription market for liraglutide as of Q4 2024 (IQVIA data), largely from brand recognition and the savings card.

Can I Switch From Saxenda to Generic Liraglutide Mid-treatment?

Yes, with your prescriber’s approval. The molecule and dosing schedule are identical. Pen design differs slightly between Saxenda and the Hikma generic, so review the new pen’s instructions before first use. No washout period or titration change needed.

Does TrimRx Prescribe Liraglutide?

TrimRx’s medical team focuses on semaglutide and tirzepatide based on the stronger weight loss data from STEP and SURMOUNT trials. We don’t prescribe liraglutide for new weight loss patients. Take our free assessment quiz to see which option fits your clinical picture.

Is Compounded Liraglutide Legal in 2026?

Only in narrow cases. After the FDA removed liraglutide from the shortage list in 2024, routine compounding by 503A and 503B pharmacies is no longer permitted. Patient-specific compounds for documented allergies to brand inactive ingredients remain legal.

What’s the Cheapest Way to Get Liraglutide Right Now?

For diabetes, Victoza with the Novo savings card at 25 dollars per month if you have commercial insurance. For obesity, generic liraglutide cash-pay at Cost Plus Drugs or via GoodRx coupons, typically 287 to 400 dollars per month.

Disclaimer: This content is for informational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any disease or condition. Individual results may vary. Always consult a qualified healthcare professional before starting any weight loss program or medication.